# DESCRIPTION

## TECHNICAL FIELD

- introduce Streptococcus pneumoniae pneumolysin

## BACKGROUND

- describe Streptococcus pneumoniae
- discuss current pneumococcal vaccines
- motivate need for new vaccines

## SUMMARY OF THE DISCLOSURE

- introduce modified pneumolysin proteins

## DETAILED DESCRIPTION

- introduce modified pneumolysin (PLY) polypeptides and fragments
- describe wild-type PLY (wtPLY) sequence and structure
- exemplify modified PLY (mPLY) polypeptides and their modifications
- describe assays for characterizing PLY activity, including in vitro hemolysis and hemolysis inhibition assays
- detail in vitro hemolysis assay and hemolysis inhibition assay protocols
- discuss macrophage activation and cytokine production assays for identifying suitable mPLY
- describe animal models for testing antibodies
- outline methods for evaluating immunogenic properties
- discuss use of mPLY polypeptides in immunological compositions
- describe generation of modified PLY polypeptides
- outline uses of mPLY polypeptides in vaccines and immunogenic compositions
- describe amino acid substitutions
- motivate conservative substitutions
- describe fusion polypeptide segments
- describe labeling and detection methods
- describe assay combinations
- define expression vectors
- describe transcriptional regulatory regions
- discuss viral and non-viral vectors
- detail retroviral vectors
- describe adenoviral vectors
- discuss adeno-associated virus vectors
- describe poxvirus vectors
- outline non-viral plasmid vectors and delivery techniques
- describe pharmaceutical carriers and formulations
- list adjuvants and their mechanisms
- discuss co-stimulatory components and cytokines
- define antibodies and their derivatives
- describe methods of preparing and utilizing antibodies
- outline kits for detecting streptococcus infection
- provide general definitions and explanations

## EXAMPLES

### Example 1

- generate expression plasmids for wtPLY and His-tagged wtPLY

### Example 2

- generate expression plasmids for PLY(T65C, G293C, C428A) (PlyD1) and His-tagged

### Example 3

- purify PlyD1 PLY (T65C, G293C, C428A)

### Example 4

- perform in vitro hemolytic assay

### Example 5

- generate anti-PlyD1 antibodies
- assess antibody-mediated inhibition of wtPLY activity

### Example 6

- evaluate immunogenicity of PlyD1 and adjuvantation

### Example 7

- perform TLR4 assay

### Example 8

- describe sepsis model
- present results of PlyD1 immunization in sepsis model
- describe focal pneumonia model
- describe intranasal challenge model
- summarize results of PlyD1 immunization in intranasal challenge model

### Example 9

- describe production process of PlyD1 immunogenic composition and/or vaccine

